Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.
Ramaswamy B, Povoski SP, Rhoades C, Allen J, Hauger M, Young D, Burak W, Farrar W, Yee L, Kendra K, Somasundaram S, Orlowski RZ, Shapiro CL.
Ramaswamy B, et al. Among authors: shapiro cl.
Breast Cancer Res Treat. 2005 Sep;93(1):67-74. doi: 10.1007/s10549-005-3784-z.
Breast Cancer Res Treat. 2005.
PMID: 16184461
Clinical Trial.